SG Americas Securities, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,976
-99.2%
197,884
+197.8%
0.04%
+600.0%
Q3 2022$393,000
+72.4%
66,443
+452.8%
0.01%
+400.0%
Q4 2021$228,000
-68.7%
12,020
-45.1%
0.00%
-66.7%
Q3 2021$729,000
+235.9%
21,896
+291.7%
0.00%
+200.0%
Q2 2021$217,000
-79.2%
5,590
-74.1%
0.00%
-80.0%
Q1 2021$1,042,000
+72.5%
21,612
+86.3%
0.01%
+66.7%
Q4 2020$604,000
-57.0%
11,603
-77.9%
0.00%
-66.7%
Q3 2020$1,405,000
+428.2%
52,511
+284.8%
0.01%
+350.0%
Q2 2020$266,000
+60.2%
13,645
-19.0%
0.00%0.0%
Q1 2020$166,000
+8.5%
16,853
-38.2%
0.00%
+100.0%
Q3 2019$153,000
-42.7%
27,266
-11.6%
0.00%
-50.0%
Q2 2019$267,000
+13.1%
30,858
+5.0%
0.00%0.0%
Q1 2019$236,000
+50.3%
29,377
-23.3%
0.00%
+100.0%
Q4 2018$157,000
+86.9%
38,285
+154.9%
0.00%0.0%
Q3 2018$84,000
-22.9%
15,022
+117.6%
0.00%0.0%
Q4 2014$109,0006,9050.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders